Biochemistry of Coagulation - Goueli Flashcards
1
Q
What does Aspirin inhibit?
A
- Primary Hemostasis
- irreversibly inhibits COX-1 from generating Thromboxane A2
- Low-dose aspirin use irreversibly blocks the formation of thromboxane A2 in platelets, producing an inhibitory effect on platelet aggregation during the lifetime of the affected platelet (8–9 days)
2
Q
What does the von Willebrand Factor (vWF) do?
A
- mediates the adhesion of platelets to the collagen exposed on endothelial cell surfaces
- acts as a bridge between GP Ib-GP V-GP IX complex on the surface of platelets and collagen fibrils
- also binds to and stabilizes coagulation factor VIII
3
Q
What is the MOA of Warfarin (Coumadin)?
A
- Slow and long acting blood anticoagulant with a structure resembling that of Vitamin K
- Similar structure allows the compound to compete with Vitamin K
- blocks the vitK reductase enzymes used to regenerative active vitK
- Prevent gamma-carboxylation of glutamate residues in factors II, VII, IX, X, and proteins C and S
- factors consequently cannot bind calcium and thus cannot bind to their phospholipid membrane sites of activation
- blocks the vitK reductase enzymes used to regenerative active vitK
4
Q
What is the primary reason a physician must “bridge with heparin” when starting a patient on Warfarin (Coumadin)?
A
- Warfarin (Coumadin) also blocks the activity of proteins S and C
- loss of anticoagulant factors leads to increased risk of clotting initially
5
Q
What is the MOA of Heparin?
A
- Binds to and activates Antithrombin III
- leads to thrombin inactivation
- also blocks the activity of factors:
- VIIIa
- IXa
- Xa
- XIa
6
Q
What is the difference between HMW Heparin and LMW? When do you give each?
A
- HMW heparin
- binds to plasma proteins and cell surfaces in addition to its primary target (ATIII)
- use for loading dose
- LMW heparin
- fewer nonspecific interactions than HMW
- effects are easier to predict
- constant monitoring isn’t reguired
- use for short-term or long-term use